Ambulatory blood pressure monitoring is an effective diagnosis method for hypertension.
In fact, hypertension is one of the most common chronic diseases in the USA.
A statistic by the American Society of Hypertension (ASH) mentions that over 100 billion adults in the United States are diagnosed with hypertension, over 46,000 people passed away from cardiovascular diseases caused by hypertension, and over 100,000 people passed away from strokes caused by hypertension.
The U.S. economy loses an estimated $131 billion in medical costs, lost work time, and reduced productivity related to high blood pressure.
These numbers are shocking! Perhaps, this is one of the reasons why ambulatory blood pressure monitoring has been rapidly promoted and popularized in the United States.
Ambulatory blood pressure monitoring is one of the recognized diagnostic methods for hypertension, white coat hypertension (WCH), and masked hypertension (MH) by many doctors and medical institutions. Not only in the United States, but it has also been well promoted and applied in many European countries. In Germany, Spain, France, and the United Kingdom (former EU members), the results of ambulatory blood pressure monitoring are used as one of the diagnostic criteria for hypertension.
- In the joint guidelines issued by the ASH and the International Society of Hypertension (ISH) in 2013, they emphasized the importance of ambulatory blood pressure monitoring in the diagnosis of hypertension and recommended it as one of the preferred methods for diagnosing hypertension.
- The National Heart, Lung, and Blood Institute in the United States also supports the use of ambulatory blood pressure monitoring to evaluate and treat hypertension, especially for patients who may have “WCH”.
With social progress and the improvement of overall living standards, people’s health awareness has also been raised. More and more people are paying attention to their own and their family’s health, taking proactive health measures, and improving health literacy, and quality of life. In the United States, the mention of health issues on social media is very high. The US government and some related organizations are also actively promoting health education and health management.
Currently, ambulatory blood pressure monitoring has been included in some healthcare plans in the United States. In 2019, the federal healthcare plan Medicare announced the approval of ambulatory blood pressure monitoring as part of hypertension evaluation and paid for related medical expenses. At the same time, some private medical insurance also began to cover ambulatory blood pressure monitoring, including Aetna, Blue Cross Blue Shield, Cigna, and others.
It is worth noting that different healthcare plans may have different payment policies and requirements for ambulatory blood pressure monitoring, and specific circumstances may need to be consulted with relevant personnel from healthcare plans and insurance companies. In addition, ambulatory blood pressure monitoring also requires a doctor’s prescription to be eligible for healthcare or insurance company payment, and patients should undergo relevant examinations under the doctor’s advice.
In conclusion, the application and research of ambulatory blood pressure monitoring in the United States have become quite mature and have been widely recognized and promoted.
Currently, there are many companies that have high-quality and high-precision ambulatory blood pressure monitors. Of course, we also have similar products, but they are currently in the FDA application stage. If you are interested in this product, please feel free to contact us, or click here.
Thank you so much for reading our content, and be well. 🙂
References:
- Centers for Disease Control and Prevention. Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among U.S. Adults Aged 18 Years and Older Applying the Criteria from the American College of Cardiology and American Heart Association’s 2017 Hypertension Guideline—NHANES 2015–2018. Atlanta, GA: U.S. Department of Health and Human Services; 2021. Accessed March 12, 2021.
- Centers for Medicare & Medicaid Services. National Coverage Determination (NCD) – Ambulatory Blood Pressure Monitoring.